Objective: To compare the efficacy and safety in treatment of benign prostatichyperplasia (BPH) between bipolar transurethral plasmakinetic prostatectomy (TUPKP)and transurethral resection of the prostate (TURP) by observing the related clinicalindicators.Methods: Collected60cases of BPH patients of Second Affiliated Hospital ofDalian Medical University between Mar2012and Mar2013, made them into twogroups (TURP group and TUPKP group) and gave each group30cases in according tothe different operation ways. Be registered separately and the information that is thebasic available to two groups of admission in patients with. According to the groupingdifferent select the appropriate surgery way and record the the resection of the size ofthe glandular tissue, surgical time-consuming, the postoperative-inspection, and withpost-operative hearing carried out on the the patient in January referral. The clinicalobserving indexes of will the two groups of the patient’s was used for statisticalcomparative analysis of.Results: There were no difference between the basic available to two groups ofadmission in patients and the size of resection of prostate weight (P>0.05). When theTUPKP and the TURP group in the preoperative IPSS (28.53±3.87,29.10±3.88),QOL (4.99±0.38,5.02±0.35) with postoperative IPSS (9.33±2.10,9.25±1.89), QOL(1.49±0.70,1.52±0.60) were compared, the results are different (P <0.05), but nodifference (P>0.05) between the two groups when comparing. Description two kinds ofsurgery could significantly lifting of the patient’s preoperative symptoms, improve thequality of life of the patients. In the were compared between the two groupspostoperative the decreasing in hemoglobin (5.03±1.31,7.22±1.45), the low level ofthe serum sodium (3.33±0.45,3.86±0.83), operative time (63.90±4.12,68.64±3.38), length of stay (5.13±1.04,6.36±2.01), complication rate was very significant (P<0.05), which means that that TUPKP have advantage in some aspects among thedecreasing vessel bleeding, length of stay, operation time and complication rate.Conclusions: The two groups has similar efficacy treatment in BPH. ComparedTUPKP to TURP, TUPKP can reduce the risk factors. |